JPRN-UMIN000013682已完成未知
The lipid lowering effect of anagliptin in type2 diabetes mellitus with dyslipidemia - The lipid lowering effect of anagliptin in type2 diabetes mellitus with dyslipidemia
Internal Medicine, Teikyo University School of Medicine0 个研究点目标入组 40 人开始时间: 2014年4月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who accord the contraindication of anagliptin. 2.Patients whose HbA1c over 8.0% before entry. 3.Patients who suffered coronary heart disease in past. 4.Patients whose renal function is declined (Ccr below the 30) or ongoing dialysis. 5.Individuals who are ineligible in the opinion of the physician in charge.
研究者
相似试验
已完成
不适用
Effect of anagliptin on lipid profile in type 2 diabetic patients with hyperlipidemiaType 2 diabetesJPRN-UMIN000013878Yokohama City University Hospital30
已完成
不适用
Comparison of lipid lowering effect of anagliptin and miglitol in patients with type 2 diabetesJPRN-UMIN000021494Yokohama City University60
已完成
不适用
The effect of anagliptin on blood glucose and lipid levels in type 2 diabetes melliusType 2 diabetes mellitusJPRN-UMIN000012533Yokohama City University Medical Center100
已完成
不适用
Effect of anagliptin on lipid metabolism in non-diabetic meHyperlipidemiaJPRN-UMIN000011355Yokohama City University Hospital30
已完成
不适用
The efficacy of anagliptin in patients with type 2 diabetes mellitusJPRN-UMIN000027103Juntendo University Urayasu Hospital30